The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Gosling Matthew M since 2009.
The trader's CIK number is 1367754.
At the time of the last reporting, Gosling Matthew M was the VP, General Counsel of Assertio Therapeutics, Inc. (stock ticker symbol ASRT).
Also see all insider trading activities at Assertio Therapeutics, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | DEPO | 0 | $0 | 65,193 | $438,610 | 0 | $0 |
| 2017 | DEPO | 0 | $0 | 59,212 | $673,299 | 0 | $0 |
| 2014 | DEPO | 0 | $0 | 101,694 | $1,552,482 | 96,875 | $530,343 |
| 2013 | DEPO | 0 | $0 | 5,692 | $47,835 | 0 | $0 |
| 2012 | DEPO | 0 | $0 | 68,317 | $398,998 | 48,125 | $148,706 |
| 2009 | DEPO | 0 | $0 | 27,724 | $101,691 | 15,000 | $29,700 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-05-11 | DEPO | Sale | 19,674 | 7.07 | 139,095 |
| 2018-03-07 | DEPO | Sale | 45,519 | 6.58 | 299,515 |
| 2017-05-11 | DEPO | Sale | 59,212 | 11.37 | 673,299 |
| 2014-12-02 | DEPO | Sale | 8,819 | 15.85 | 139,807 |
| 2014-11-19 | DEPO | Option Ex | 71,000 | 6.17 | 438,070 |
| 2014-11-19 | DEPO | Sale | 71,000 | 15.36 | 1,090,347 |
| 2014-05-09 | DEPO | Option Ex | 4,000 | 6.17 | 24,680 |
| 2014-03-14 | DEPO | Option Ex | 21,875 | 3.09 | 67,593 |
| 2014-03-14 | DEPO | Sale | 21,875 | 14.73 | 322,328 |
| 2013-12-02 | DEPO | Sale | 5,692 | 8.40 | 47,835 |
| 2012-12-12 | DEPO | Sale | 65,702 | 5.84 | 383,831 |
| 2012-12-12 | DEPO | Option Ex | 48,125 | 3.09 | 148,706 |
| 2012-12-06 | DEPO | Sale | 2,615 | 5.80 | 15,167 |
| 2009-08-11 | DEPO | Option Ex | 15,000 | 1.98 | 29,700 |
| 2009-08-11 | DEPO | Sale | 27,724 | 3.67 | 101,691 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gosling Matthew M (VP, General Counsel of Assertio Therapeutics, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.